ABT
Abbott Laboratories
NYSE: ABT · HEALTHCARE · MEDICAL DEVICES
$90.79
-0.59% today
Updated 2026-04-30
Market cap
$158.70B
P/E ratio
25.58
P/S ratio
3.52x
EPS (TTM)
$3.57
Dividend yield
2.60%
52W range
$90 – $136
Volume
11.9M
Abbott Laboratories (ABT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.90%
Operating margin
16.50%
ROE
13.00%
ROA
6.63%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $22.48B | $1.72B | 57.14% | 19.29% | 7.64% |
| 2007 | $25.91B | $3.61B | 56.29% | 19.08% | 13.92% |
| 2008 | $29.53B | $4.88B | 57.72% | 20.62% | 16.53% |
| 2009 | $30.77B | $5.75B | 57.27% | 21.36% | 18.68% |
| 2010 | $35.17B | $4.63B | 58.56% | 20.05% | 13.15% |
| 2011 | $38.85B | $4.73B | 60.33% | 17.61% | 12.17% |
| 2012 | $39.87B | $5.96B | 27.22% | 5.03% | 14.95% |
| 2013 | $21.85B | $2.58B | 45.12% | 9.82% | 11.79% |
| 2014 | $20.25B | $2.28B | 51.81% | 14.40% | 11.28% |
| 2015 | $20.41B | $4.42B | 53.71% | 14.45% | 21.68% |
| 2016 | $20.85B | $1.40B | 53.92% | 15.58% | 6.71% |
| 2017 | $27.39B | $477.00M | 47.70% | 7.20% | 1.74% |
| 2018 | $30.58B | $2.37B | 51.75% | 12.57% | 7.74% |
| 2019 | $31.90B | $3.69B | 52.32% | 14.39% | 11.56% |
| 2020 | $34.61B | $4.50B | 50.21% | 15.29% | 12.99% |
| 2021 | $43.08B | $7.07B | 53.89% | 21.36% | 16.42% |
| 2022 | $43.65B | $6.93B | 51.14% | 19.16% | 15.88% |
| 2023 | $40.11B | $5.72B | 49.96% | 16.04% | 14.27% |
| 2024 | $41.95B | $13.40B | 50.83% | 16.27% | 31.95% |
| 2025 | $44.33B | $6.52B | 55.51% | 18.16% | 14.72% |